Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

19,100 public trials 1,287 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Active, not recruiting

Optimizing Tobacco Use Treatment for PLWHA

NCT04176172

Conditions
Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +26 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA

NCT04942210

Conditions
Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +8 more
Locations
  • Emory University Decatur- Site Number : 8400005 Decatur, Georgia, United States
  • Velocity Clinical Research- New Orleans Site Number : 8400008 New Orleans, Louisiana, United States
  • Johns Hopkins Bloomberg School of Public Health (JHSPH)- Site Number : 8400004 Baltimore, Maryland, United States
  • Harvard University Medical School- Site Number : 8400002 Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

NCT06947499

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations
  • Care CT Group Dasmariñas, Cavite, Philippines
View Trial Details
Active, not recruiting

A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma

NCT04047251

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Dana Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, not recruiting

Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)

NCT03998254

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +10 more
Locations
  • Lingchuan Center for Disease Control and Prevention ( Site 0002) Guilin, Guangxi, China
  • Quanzhou Center for Disease Control and Prevention ( Site 0001) Guilin, Guangxi, China
  • Xiangyuan Center for Disease Control and Prevention ( Site 0003) Changzhi, Shanxi, China
  • Yanhu Center for Disease Control and Prevention of Yuncheng ( Site 0004) Yuncheng, Shanxi, China
View Trial Details

Related conditions